{"id":"W2590066672","doi":"10.1200/jco.2014.32.4_suppl.425","title":"Response to systemic therapy in non-clear cell renal cell carcinomas: A systematic review and meta-analysis.","year":2014,"lang":"en","type":"review","venue":"Journal of Clinical Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Sunitinib; Pazopanib; Temsirolimus; Clear cell renal cell carcinoma; Oncology; Internal medicine; Sorafenib; Renal cell carcinoma; Clinical endpoint; Progression-free survival; Everolimus; Meta-analysis; Clinical trial; Chemotherapy; Hepatocellular carcinoma; Discovery and development of mTOR inhibitors; PI3K/AKT/mTOR pathway","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01161048,0.002064573,0.0159228,0.006770078,0.0004611948,0.002339069,0.001596894,0.001650229,0.002710994],"category_scores_gemma":[0.02105065,0.001120118,0.03013279,0.008610182,0.0006070145,0.00144912,0.001136431,0.001260879,0.0002934867],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00195891,"about_ca_system_score_gemma":0.002825141,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005601626,"about_ca_topic_score_gemma":0.01375312,"domain_scores_codex":[0.9917648,0.003866601,0.002429017,0.0008812491,0.0008393655,0.0002188525],"domain_scores_gemma":[0.9832719,0.01219227,0.002947235,0.00043733,0.000949401,0.0002018345],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.001318833,0.00001973228,0.004818332,0.375686,0.6068729,0.0001121141,0.00006822707,0.0004458672,0.0002118875,0.00009460546,0.0005506859,0.009800854],"study_design_scores_gemma":[0.0004703134,0.000177747,0.004902728,0.0256587,0.9665025,0.0001159284,0.00004367407,0.000169447,0.0001025302,0.0001504654,0.0016853,0.00002054925],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004695409,0.9934065,0.0004453064,0.0001623486,0.000080889,0.0002111341,0.0007797247,0.00001615031,0.0002025221],"genre_scores_gemma":[0.1918838,0.8024894,0.00196394,0.000744896,0.0001880696,0.001054777,0.001378243,0.00002761094,0.0002692902],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.0159228,"threshold_uncertainty_score":0.0614028,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2410394227245558,"score_gpt":0.4832609885759588,"score_spread":0.242221565851403,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}